GAD THOMAS (President and Chairman) sold 13.9% of their position (136.16K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.06M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/7/2022ACC: 0001104659-22-012868
DirectorOfficer· President and Chairman
Since Sep 2018
-136.16K
Net shares
Net seller
$1.06M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
136.16K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−35.06K
Price / share
$7.90
Trade value
$277.03K
% of position
3.6%
2/3/2022
982.37K→947.31K
Common Stock
Indirect
Shares
−101.10K
Price / share
$7.70
Trade value
$778.53K
% of position
10.7%
2/4/2022
947.31K→846.20K
Total
Net shares
−136.16K
Net value
-$1.06M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/3/2022 | S · Sale | −35.06K | $7.90 | $277.03K | 3.6% | 982.37K | 947.31K |
| Common Stock Indirect | 2/4/2022 | S · Sale | −101.10K | $7.70 | $778.53K | 10.7% | 947.31K | 846.20K |
| Total | −136.16K | -$1.06M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
DirectShares owned50K
Common Stock
IndirectShares owned60K
Total
50K direct·60K indirect110K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 50K | Direct |
| Common Stock | 60K | Indirect |
| Total | 110K | 50K direct·60K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported